Registro:

Referencias:

• Archer, T.K., Lefebvre, P., Wolford, R.G., Hager, G.L., Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation (1992) Science, 255, pp. 1573-1576
• Ashwell, J.D., Lu, F.W., Vacchio, M.S., Glucocorticoids in T cell development and function* (2000) Annu. Rev. Immunol., 18, pp. 309-345
• Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A., Karin, M., Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis (1995) Science, 270, pp. 286-290
• Ayroldi, E., D'Adamio, F., Zollo, O., Agostini, M., Moraca, R., Cannarile, L., Migliorati, G., Riccardi, C., Cloning and expression of a short Fas ligand: a new alternatively spliced product of the mouse Fas ligand gene (1999) Blood, 94, pp. 3456-3467
• Baumann, S., Dostert, A., Novac, N., Bauer, A., Schmid, W., Fas, S.C., Krueger, A., Krammer, P.H., Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer (2005) Blood, 106, pp. 617-625
• Bidere, N., Su, H.C., Lenardo, M.J., Genetic disorders of programmed cell death in the immune system (2006) Annu. Rev. Immunol., 24, pp. 321-352
• Bielekova, B., Lincoln, A., McFarland, H., Martin, R., Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases (2000) J. Immunol., 164, pp. 1117-1124
• Bouillet, P., O'Reilly, L.A., CD95, BIM and T cell homeostasis (2009) Nat. Rev. Immunol., 9, pp. 514-519
• Brown, K., Park, S., Kanno, T., Franzoso, G., Siebenlist, U., Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha (1993) Proc. Natl. Acad. Sci. U.S.A., 90, pp. 2532-2536
• Castellano, R., Vire, B., Pion, M., Quivy, V., Olive, D., Hirsch, I., Van, L.C., Collette, Y., Active transcription of the human FASL/CD95L/TNFSF6 promoter region in T lymphocytes involves chromatin remodeling: role of DNA methylation and protein acetylation suggest distinct mechanisms of transcriptional repression (2006) J. Biol. Chem., 281, pp. 14719-14728
• Chen, F.E., Ghosh, G., Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views (1999) Oncogene, 18, pp. 6845-6852
• De Bosscher, K., Haegeman, G., Minireview: latest perspectives on antiinflammatory actions of glucocorticoids (2009) Mol. Endocrinol., 23, pp. 281-291
• del Rey, A., Roggero, E., Kabiersch, A., Schafer, M., Besedovsky, H.O., The role of noradrenergic nerves in the development of the lymphoproliferative disease in Fas-deficient, lpr/lpr mice (2006) J. Immunol., 176, pp. 7079-7086
• Delgado, M., Ganea, D., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3 (2001) J. Immunol., 166, pp. 1028-1040
• Dostert, A., Heinzel, T., Negative glucocorticoid receptor response elements and their role in glucocorticoid action (2004) Curr. Pharm. Des., 10, pp. 2807-2816
• Duran, A., Diaz-Meco, M.T., Moscat, J., Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation (2003) EMBO J., 22, pp. 3910-3918
• Fuld, S., Borland, G., Yarwood, S.J., Elevation of cyclic AMP in Jurkat T-cells provokes distinct transcriptional responses through the protein kinase A (PKA) and exchange protein activated by cyclic AMP (EPAC) pathways (2005) Exp. Cell Res., 309, pp. 161-173
• Gao, H.B., Tong, M.H., Hu, Y.Q., You, H.Y., Guo, Q.S., Ge, R.S., Hardy, M.P., Mechanisms of glucocorticoid-induced Leydig cell apoptosis (2003) Mol. Cell Endocrinol., 199, pp. 153-163
• Grader-Beck, T., van Puijenbroek, A.A., Nadler, L.M., Boussiotis, V.A., CAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression (2003) Blood, 101, pp. 998-1006
• Green, D.R., Droin, N., Pinkoski, M., Activation-induced cell death in T cells (2003) Immunol. Rev., 193, pp. 70-81
• Herold, M.J., McPherson, K.G., Reichardt, H.M., Glucocorticoids in T cell apoptosis and function (2006) Cell Mol. Life. Sci., 63, pp. 60-72
• Holtz-Heppelmann, C.J., Algeciras, A., Badley, A.D., Paya, C.V., Transcriptional regulation of the human FasL promoter-enhancer region (1998) J. Biol. Chem., 273, pp. 4416-4423
• Hsu, S.C., Gavrilin, M.A., Lee, H.H., Wu, C.C., Han, S.H., Lai, M.Z., NF-kappa B-dependent Fas ligand expression (1999) Eur. J. Immunol., 29, pp. 2948-2956
• Ivanov, V.N., Nikolic-Zugic, J., Transcription factor activation during signal-induced apoptosis of immature CD4(+)CD8(+) thymocytes. A protective role of c-Fos (1997) J. Biol. Chem., 272, pp. 8558-8566
• Iwata, M., Hanaoka, S., Sato, K., Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire (1991) Eur. J. Immunol., 21, pp. 643-648
• Kasibhatla, S., Genestier, L., Green, D.R., Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB (1999) J. Biol. Chem., 274, pp. 987-992
• Krammer, P.H., Arnold, R., Lavrik, I.N., Life and death in peripheral T cells (2007) Nat. Rev. Immunol., 7, pp. 532-542
• Lee, M.R., Liou, M.L., Yang, Y.F., Lai, M.Z., CAMP analogs prevent activation-induced apoptosis of T cell hybridomas (1993) J. Immunol., 151, pp. 5208-5217
• Lin, B., Williams-Skipp, C., Tao, Y., Schleicher, M.S., Cano, L.L., Duke, R.C., Scheinman, R.I., NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type (1999) Cell Death Differ., 6, pp. 570-582
• McKean, D.J., Bell, M., Huntoon, C., Rastogi, S., Van Norstrand, M., Podzorski, R., Nilson, A., Paya, C., IL-1 receptor and TCR signals synergize to activate NF-kappa B-mediated gene transcription (1995) Int. Immunol., 7, pp. 9-20
• Menet, J.S., Abruzzi, K.C., Desrochers, J., Rodriguez, J., Rosbash, M., Dynamic PER repression mechanisms in the Drosophila circadian clock: from on-DNA to off-DNA (2010) Genes Dev., 24, pp. 358-367
• Mercurio, F., Didonato, J., Rosette, C., Karin, M., Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105 (1992) DNA Cell Biol., 11, pp. 523-537
• Mittelstadt, P.R., Ashwell, J.D., Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression (1998) Mol. Cell Biol., 18, pp. 3744-3751
• Mosenden, R., Tasken, K., Cyclic AMP-mediated immune regulation - overview of mechanisms of action in T cells (2011) Cell Signal, 23, pp. 1009-1016
• Muller, I.L., Refojo, D., Costas, M.A., Holsboer, F., Arzt, E., CRE-mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid-mediated programmed cell death (2002) Biochim. Biophys. Acta, 1542, pp. 139-148
• Novac, N., Baus, D., Dostert, A., Heinzel, T., Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter (2006) FASEB J., 20, pp. 1074-1081
• Ollivier, V., Parry, G.C., Cobb, R.R., de Prost, D., Mackman, N., Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells (1996) J. Biol. Chem., 271, pp. 20828-20835
• Parry, G.C., Mackman, N., Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription (1997) J. Immunol., 159, pp. 5450-5456
• Paulsen, M., Janssen, O., Pro- and anti-apoptotic CD95 signaling in T cells (2011) Cell Commun. Signal, 9, p. 7
• Peter, M.E., Budd, R.C., Desbarats, J., Hedrick, S.M., Hueber, A.O., Newell, M.K., Owen, L.B., Lynch, D.H., The CD95 receptor: apoptosis revisited (2007) Cell, 129, pp. 447-450
• Philips, A., Maira, M., Mullick, A., Chamberland, M., Lesage, S., Hugo, P., Drouin, J., Antagonism between Nur77 and glucocorticoid receptor for control of transcription (1997) Mol. Cell Biol., 17, pp. 5952-5959
• Pinkoski, M.J., Droin, N.M., Lin, T., Genestier, L., Ferguson, T.A., Green, D.R., Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 16174-16179
• Rammes, G., Steckler, T., Kresse, A., Schutz, G., Zieglgansberger, W., Lutz, B., Synaptic plasticity in the basolateral amygdala in transgenic mice expressing dominant-negative cAMP response element-binding protein (CREB) in forebrain (2000) Eur. J. Neurosci., 12, pp. 2534-2546
• Refojo, D., Liberman, A.C., Giacomini, D., Carbia, N.A., Graciarena, M., Echenique, C., Paez, P.M., Arzt, E., Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells (2003) Ann. N. Y. Acad. Sci., 992, pp. 196-204
• Rupprecht, R., Arriza, J.L., Spengler, D., Reul, J.M., Evans, R.M., Holsboer, F., Damm, K., Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor (1993) Mol. Endocrinol., 7, pp. 597-603
• Sasaki, T., Suzuki, H., Yagi, K., Furuhashi, M., Yao, R., Susa, S., Noda, T., Kato, M., Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc (2003) Cancer Res., 63, pp. 801-806
• Schmidt, M., Lugering, N., Lugering, A., Pauels, H.G., Schulze-Osthoff, K., Domschke, W., Kucharzik, T., Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis (2001) J. Immunol., 166, pp. 1344-1351
• Skalhegg, B.S., Tasken, K., Hansson, V., Huitfeldt, H.S., Jahnsen, T., Lea, T., Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex (1994) Science, 263, pp. 84-87
• Smith, C.L., Hager, G.L., Transcriptional regulation of mammalian genes in vivo. A tale of two templates (1997) J. Biol. Chem., 272, pp. 27493-27496
• Strasser, A., Jost, P.J., Nagata, S., The many roles of FAS receptor signaling in the immune system (2009) Immunity, 30, pp. 180-192
• Sun, S.C., Ganchi, P.A., Ballard, D.W., Greene, W.C., NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway (1993) Science, 259, pp. 1912-1915
• Tanos, T., Marinissen, M.J., Leskow, F.C., Hochbaum, D., Martinetto, H., Gutkind, J.S., Coso, O.A., Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light (2005) J. Biol. Chem., 280, pp. 18842-18852
• van den Brink, M.R., Kapeller, R., Pratt, J.C., Chang, J.H., Burakoff, S.J., The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells (1999) J. Biol. Chem., 274, pp. 11178-11185
• Vossler, M.R., Yao, H., York, R.D., Pan, M.G., Rim, C.S., Stork, P.J., CAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway (1997) Cell, 89, pp. 73-82
• Weinlich, R., Bortoluci, K.R., Chehab, C.F., Serezani, C.H., Ulbrich, A.G., Peters-Golden, M., Russo, M., marante-Mendes, G.P., TLR4/MYD88-dependent, LPS-induced synthesis of PGE2 by macrophages or dendritic cells prevents anti-CD3-mediated CD95L upregulation in T cells (2008) Cell Death Differ., 15, pp. 1901-1909
• Yang, Y., Mercep, M., Ware, C.F., Ashwell, J.D., Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids (1995) J. Exp. Med., 181, pp. 1673-1682
• Zacharchuk, C.M., Mercep, M., Chakraborti, P.K., Simons, S.S., Ashwell, J.D., Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic (1990) J. Immunol., 145, pp. 4037-4045
• Zhang, L., Insel, P.A., The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells (2004) J. Biol. Chem., 279, pp. 20858-20865
• Zhong, H., SuYang, H., Erdjument-Bromage, H., Tempst, P., Ghosh, S., The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism (1997) Cell, 89, pp. 413-424

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------